JIJ
Develops a quantum- and AI-enabled optimization platform for enterprises
$5.2MStrategic
Role not disclosedActivity from announced rounds
Global Brain is a Japanese investment corporation, also recorded under the expanded name Global Brain Corporation.
The firm’s own announcements connect it to WED’s receipt-based marketing and RegCell’s cell therapies for autoimmune disease. Other covered activity includes 10pct.’s combination of hotel operations and AI software. Named corporate and flagship funds remain separate.